E. coli is most preferred system used for the production of recombinant proteins in bacteria
and the availability of improved genetic tools/methods are making it more valuable than …

Monoclonal antibodies (mAbs) and antibody fragments represent the most important
biopharmaceutical products today. Because full length antibodies are glycosylated …

Since the manufacture of the first biotech product for a fledgling biopharmaceutical industry
in 1982, Escherichia coli, has played an important role in the industrial production of …

The DNA sequence used to encode a polypeptide can have dramatic effects on its
expression. Lack of readily available tools has until recently inhibited meaningful …

Recombinantly produced enzymes are applied in many fields, ranging from medicine to food
and nutrition, production of detergents, textile, leather, paper, pulp, and plastics. Thus, the …

Fermentative production of cadaverine from renewable resources may support a sustainable
biorefinery process to produce carbon-neutral nylons such as biopolyamide 510 (PA510) …

Background Production of recombinant proteins in bacteria for academic and commercial
purposes is a well established field; however the outcomes of process developments for …

Current crop pest control strategies rely on insecticidal and fungicidal sprays, plant genetic
resistance, transgenes and agricultural practices. However, many insects, plant viruses, and …

Nanobodies are single-domain antibody fragments that have garnered considerable use as
diagnostic and therapeutic agents as well as research tools. However, obtaining pure VHHs …

Most native proteins do not make optimal drugs and thus a second-and third-generation of
therapeutic proteins, which have been engineered to improve product attributes or to …